Skip to main content

MBI-226 FDA Approval Status

FDA Approved: No
Brand name: MBI-226
Generic name: omiganan pentahydrochloride
Company: Micrologix Biotech Inc
Treatment for: Infection Prophylaxis

Development timeline for MBI-226

Jan 21, 2004Micrologix Meets with FDA on MBI-226

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.